We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.9B
AUM Growth
+$404M
(+1%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
14.11%
Holding
812
New
105
Increased
224
Reduced
322
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$149M |
| 3 |
AbbVie
ABBV
|
+$148M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$129M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$846M |
| 2 |
Stanley Black & Decker
SWK
|
+$190M |
| 3 |
Citigroup
C
|
+$156M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$151M |
| 5 |
Air Products & Chemicals
APD
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 12.19% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.4% |
| 5 | Consumer Staples | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Golar LNG
GLNG
$5B
| $25.5M | 0.06% |
700,000
+650,000
| +1,300% | +$30.9M |
|
352
NOV
NOV
$6.93B
| $25.5M | 0.06% |
389,263
-61,500
| -14% | -$4.28M |
|
353
Amphenol
APH
$198B
| $25.3M | 0.06% |
1,880,000
-12,304
| -0.7% | -$157K |
|
354
Marriott International
MAR
$98.3B
| $25.1M | 0.06% |
321,405
-5,700
| -2% | -$421K |
|
|
GMCR
355
DELISTED
KEURIG GREEN MTN INC
GMCR
| $24.9M | 0.06% |
187,700
-3,200
| -2% | -$454K |
|
|
GNMK
356
DELISTED
GenMark Diagnostics, Inc
GNMK
| $24.8M | 0.06% |
1,825,227
+175,000
| +11% | +$1.96M |
|
|
FPRX
357
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $24.8M | 0.06% |
919,882
+419,882
| +84% | +$7.23M |
|
|
K
358
DELISTED
Kellanova
K
| $24.8M | 0.06% |
403,573
-7,136
| -2% | -$428K |
|
359
Rockwell Automation
ROK
$53.4B
| $24.5M | 0.06% |
220,694
+12,858
| +6% | +$1.41M |
|
|
OPLN
360
Openlane
OPLN
$4.21B
| $24.4M | 0.06% |
1,863,931
+1,453,100
| +354% | +$17.6M |
|
361
Genuine Parts
GPC
$17.1B
| $24.2M | 0.06% |
227,502
-4,100
| -2% | -$402K |
|
|
SNBR
362
DELISTED
Sleep Number
SNBR
| $24.2M | 0.06% |
896,913
+201,370
| +29% | +$5.02M |
|
363
FirstEnergy
FE
$28B
| $24.2M | 0.06% |
620,800
-2,399,700
| -79% | -$88M |
|
364
Liberty Global Class A
LBTYA
$3.62B
| $24.1M | 0.06% |
581,985
+200,058
| +52% | +$7.67M |
|
|
OA
365
DELISTED
Orbital ATK, Inc.
OA
| $23.8M | 0.06% |
205,032
+63,186
| +45% | +$7.35M |
|
|
ALR.PRB
366
DELISTED
Alere Inc
ALR.PRB
| $23.5M | 0.06% |
74,743
| – | – |
|
|
PEGI
367
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $23.5M | 0.06% |
954,412
| – | – |
|
368
Principal Financial Group
PFG
$24.3B
| $23.5M | 0.06% |
451,849
-630,335
| -58% | -$32.7M |
|
369
Roper Technologies
ROP
$38.8B
| $23.5M | 0.06% |
150,021
-2,700
| -2% | -$414K |
|
370
Thomson Reuters
TRI
$42.8B
| $23.2M | 0.06% |
495,476
+107,712
| +28% | +$4.77M |
|
371
Nucor
NUE
$58.6B
| $23.2M | 0.06% |
472,480
-8,500
| -2% | -$442K |
|
|
PETX
372
DELISTED
Aratana Therapeutics, Inc.
PETX
| $23.2M | 0.06% |
1,300,000
-275,000
| -17% | -$3.43M |
|
373
Baxter International
BAX
$13.5B
| $23.1M | 0.06% |
581,016
-836,550
| -59% | -$32.6M |
|
374
Capri Holdings
CPRI
$1.83B
| $23.1M | 0.06% |
307,317
+87,898
| +40% | +$6.55M |
|
375
DTE Energy
DTE
$29.5B
| $23M | 0.06% |
312,693
-5,523
| -2% | -$383K |
|
Similar funds
Adage Capital Partners's Q4 2014 Portfolio in Review
As of Q4 2014, Adage Capital Partners held 812 positions worth $40.9B, up 1% from $40.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.26B in Q4 2014, closing 106 positions and reducing 322 holdings. Its most notable exit was Shire pic, an estimated $846M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in AbbVie worth $154M.
- Adage Capital Partners's largest Q4 2014 buy was AbbVie: 2,352,875 shares worth $154M.
- Adage Capital Partners added most to Allergan Inc in Q4 2014, an estimated $166M increase.
- Adage Capital Partners's biggest Q4 2014 reduction was Stanley Black & Decker, cutting an estimated $190M.
- Adage Capital Partners fully exited Shire pic in Q4 2014, selling an estimated $846M.
- Adage Capital Partners's ten largest holdings make up 14% of its $40.9B portfolio in Q4 2014.
- Adage Capital Partners opened 105 new positions and closed 106 in Q4 2014.
- Adage Capital Partners's portfolio value rose 1% quarter-over-quarter to $40.9B.
Based on Adage Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.